Pharmacyclics, Inc.
(NASDAQ : PCYC)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
Loading PCYC News...
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc.
-1.32%31.150.8%$979.52m
JNJJohnson & Johnson
-0.78%111.190.7%$892.89m
MRKMerck & Co., Inc.
-0.51%59.970.8%$626.19m
BMYBristol-Myers Squibb Company
-2.05%54.880.9%$598.57m
LLYEli Lilly and Company
-0.91%67.180.6%$558.55m
ABBVAbbVie, Inc.
-2.56%60.042.2%$531.86m
NVSNovartis AG Sponsored ADR
-0.61%68.540.1%$233.09m
AZNAstraZeneca PLC Sponsored ADR
-0.54%25.871.2%$211.60m
NVONovo Nordisk A/S Sponsored ADR Class B
-0.26%35.170.2%$185.53m
GSKGlaxoSmithKline plc Sponsored ADR
-0.19%37.620.3%$168.08m
SNYSanofi Sponsored ADR
-0.25%40.560.2%$79.96m
LCILannett Company, Inc.
-4.09%23.4525.1%$25.21m
SCMPSucampo Pharmaceuticals, Inc. Class A
-3.48%15.254.3%$10.17m
AKTXAkari Therapeutics Plc Sponsored ADR
0.00%7.510.2%$0.03m
EPIXESSA Pharma Inc
-1.75%2.250.0%$0.01m

Company Profile

Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. The company has three product candidates in clinical development and several preclinical molecules in lead optimization. Its clinical development and product candidates are small-molecule enzyme inhibitors designed to target key biochemical pathways involved in human diseases with critical unmet needs. Pharmacyclics was founded on April 19, 1991 and is headquartered in Sunnyvale, CA.